The Procyrion Advantage
The Procyrion catheter deployed ventricular assist device (CVAD) provides many benefits over existing ventricular assist devices:
- Restores hemodynamics through continuous aortic flow augmentation
- Deployed and retrieved in a catheter lab
- Unloads the heart without invasive surgery and damage to the heart muscle
- Reduced stroke risk
- High perfusion of the carotid and coronary arteries (No STEAL phenomenon)
- High ambulatory patient mobility
- Potential to treat less sick patients earlier in the heart failure spectrum
The Procyrion System
The Procyrion CVAD is deployed percutaneously within the descending aorta and held axiosymmetric within the aorta by a self-expanding strut fixation system. Once the pump is activated, a micro-motor and impeller pulls fluid from the heart and restores body hemodynamics. The pump can then be retrieved through a catheter-based procedure when the heart has had a chance to heal.
The Procyrion Team
Reynolds Delgado, MD
- Founder and Inventor
- Cardiologist, Texas Heart Institute
- Email: reynolds@procyrion.com
AlphaDev, LLC
- Founder and Seed Investor
- Houston based, seed stage life
science investor - Portfolio includes medical devices,
therapeutics and services - Proven team of engineers and
business development professionals
For additional information please contact
Ben Hertzog ben@procyrion.com